BMS Decides Against Opdualag Launch In Germany

 
• By Francesca Bruce
  
Uncertain result
BMS Does Not Believe Opdualag Would Perform Well In Benefit Assessment • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography